Publications by:
Phillip Morris
Also publishes as (Charles P. Morris, C. Phillip Morris)
Up a level |
Cheah, Sern Yih, Lurie, Janine A., Lawford, Bruce R., Young, Ross McD., Morris, Charles P., and Voisey, Joanne (2016) Interaction of multiple gene variants and their effects on schizophrenia phenotypes. Comprehensive Psychiatry, 71. pp. 63-70.
Bruenig, Dagmar, Lurie, Janine, Morris, Charles P., Harvey, Wendy, Lawford, Bruce, Young, Ross McD., and Voisey, Joanne (2016) A case-control study and meta-analysis reveal BDNF Val66Met is a possible risk factor for PTSD. Neural Plasticity, 2016. 69794351.
Dannlowski, Udo, Domschke, Katharina, Birosova, Eva, Lawford, Bruce, Young, Ross, Voisey, Joanne, Morris, C. Phillip, Suslow, Thomas, Konrad, Carsten, Kugel, Harald, Ohrmann, Patricia, Bauer, Jochen, Schöning, Sonja, Zavorotnyy, Maxim, Diemer, Julia, Arolt, Volker, Baune, Bernhard T., and Zwanzger, Peter (2013) Dopamine D3 receptor gene variation: impact on electroconvulsive therapy response and ventral striatum responsiveness in depression. International Journal of Neuropsychopharmacology, 16 (7). pp. 1443-1459.
Domschke, Katharina, Lawford, Bruce, Laje, Gonzalo, Berger, Klaus, Young, Ross, Morris, Phillip, Deckert, Jürgen, Arolt, Volker, McMahon, Francis J., and Baune, Bernhard T. (2010) Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response. International Journal of Neuropsychopharmacology , 13 (1). pp. 93-101.
Domschke, Katharina, Dannlowski, Udo, Ohrmann, Patricia, Lawford, Bruce, Bauer, Jochen, Kugel, Harald, Heindel, Walter, Young, Ross, Morris, Phillip, Arolt, Volker, Deckert, Jurgen, Suslow, Thomas, and Baune, Bernhard T. (2008) Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in Major Depression. European Neuropsychopharmacology, 18 (10). pp. 751-759.